Search results
VA include a spectrum that ranges from premature ventricular complex (PVC) to ventricular fibrillation (VF), with a clinical presentation that ranges from a total lack of symptoms to cardiac arrest. Most life-threatening VA are associated with ischemic heart disease, particularly in older patients.
- Circulation
National Center. 7272 Greenville Ave.Dallas, TX 75231....
- Pulseless Electric Activity
Electric mechanisms associated with SCA are broadly...
- View PDF
efforts. Guidelines are official policy of the ACC and AHA....
- Robert J. Myerburg
Background—Coronary artery disease is identified in ≈80% of...
- Figure 1E
Rotors and antiarrhythmic drugs in ventricular fibrillation...
- A Nationwide Study in Denmark
BackgroundWe aimed to investigate the incidence and risk...
- Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports
The original Utstein definitions were revised in 2004 with...
- Lifetime Risk for Sudden Cardiac Death in The Community
We present the first lifetime risk estimates for SCD.Greater...
- Circulation
26 sie 2022 · In case of a known idiopathic VT (Figure 4), treatment with beta-blockers (for RVOT VT) 306 or verapamil (for fascicular VT) 307 is recommended for acute conversion. Although verapamil may terminate other types of idiopathic VT, 307 important adverse effects such as severe hypotension may occur.
26 sie 2022 · ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Ventricular Arrhythmias and the Prevention of Sudden Cardiac (SCD).
Comparison of recommendations regarding the treatment of patients with idiopathic premature ventricular contractions and idiopathic ventricular tachycardia according to 2022 ESC and 2017 AHA/ACC/HRS Guidelines (mentioned in the Table as AHA).
21 paź 2022 · 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43 (40):3997-4126. doi: 10.1093/eurheartj/ehac262. Authors.
The purpose of the guideline is to provide a contemporary guideline for the management of adults who have ventricular arrhythmias (VA) or who are at risk for sudden cardiac death (SCD), including diseases and syndromes associated with a risk of SCD from VA.
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Free Access. Clinical Practice Guideline
